(以下内容从华福证券《生物医药行业定期:重视传统Pharma创新转型后的又一轮成长机会》研报附件原文摘录)本周创新药行情回顾:本周(2025年19日-2025年5月23日)A股创新药涨幅前三的个股为:三生国健(+100%)、迈威生物(+19.1%)、益方生物(+16.0%),跌幅前三的个股为:盟科药业(-3.3%)、迪哲医药(-2.9%)、中源协和(-2.2%)。本周港股创新药涨幅前三的个股为:...
Source Link(以下内容从华福证券《生物医药行业定期:重视传统Pharma创新转型后的又一轮成长机会》研报附件原文摘录)本周创新药行情回顾:本周(2025年19日-2025年5月23日)A股创新药涨幅前三的个股为:三生国健(+100%)、迈威生物(+19.1%)、益方生物(+16.0%),跌幅前三的个股为:盟科药业(-3.3%)、迪哲医药(-2.9%)、中源协和(-2.2%)。本周港股创新药涨幅前三的个股为:...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.